Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 5.8B | 5.7B | 5.9B | 6.0B |
Cost of revenue | 1.9B | 132M | 1.9B | 1.8B |
Gross profit | 4.0B | 5.5B | 4.0B | 4.2B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | 1.5B | 1.5B | 1.7B | 1.6B |
Other operating expenses | 56M | 1.8B | 15M | 16M |
Operating income | 2.1B | 2.0B | 2.0B | 2.2B |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | 47M | 38M | 31M | 36M |
Other income expense | -171M | -571M | 133M | -42M |
Pretax income | 1.9B | 1.6B | 2.1B | 2.2B |
Tax provision | 414M | 373M | 461M | 470M |
Net income | 1.5B | 1.3B | 1.7B | 1.7B |
Basic EPS | 2.7 | 2.3 | 3.0 | 3.0 |
Diluted EPS | 2.7 | 2.2 | 3.0 | 3.0 |
Basic average shares | 550M | 557M | 564M | 569M |
Diluted average shares | 553M | 561M | 568M | 572M |
EBITDA | 3.2B | 3.0B | 3.1B | 3.3B |
Net income from continuing op. | 1.5B | 1.3B | 1.7B | 1.7B |
Minority interests | — | — | — | — |
Preferred stock dividends | — | — | — | — |